ES2900325T3 - Métodos y dispositivos para aislar el plomo 203 - Google Patents
Métodos y dispositivos para aislar el plomo 203 Download PDFInfo
- Publication number
- ES2900325T3 ES2900325T3 ES15779451T ES15779451T ES2900325T3 ES 2900325 T3 ES2900325 T3 ES 2900325T3 ES 15779451 T ES15779451 T ES 15779451T ES 15779451 T ES15779451 T ES 15779451T ES 2900325 T3 ES2900325 T3 ES 2900325T3
- Authority
- ES
- Spain
- Prior art keywords
- column
- sodium hydroxide
- solution
- mci
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- WABPQHHGFIMREM-AHCXROLUSA-N lead-203 Chemical compound [203Pb] WABPQHHGFIMREM-AHCXROLUSA-N 0.000 title claims abstract description 71
- 238000000034 method Methods 0.000 title claims abstract description 31
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims abstract description 120
- 229920001429 chelating resin Polymers 0.000 claims abstract description 22
- 238000010828 elution Methods 0.000 claims abstract description 21
- 239000000203 mixture Substances 0.000 claims description 23
- 229910052751 metal Inorganic materials 0.000 claims description 18
- 239000002184 metal Substances 0.000 claims description 17
- 239000000356 contaminant Substances 0.000 claims description 13
- NBZBKCUXIYYUSX-UHFFFAOYSA-N iminodiacetic acid Chemical compound OC(=O)CNCC(O)=O NBZBKCUXIYYUSX-UHFFFAOYSA-N 0.000 claims description 11
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 7
- 239000000243 solution Substances 0.000 description 41
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 20
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 15
- 239000010949 copper Substances 0.000 description 15
- 229910017604 nitric acid Inorganic materials 0.000 description 15
- 229920005989 resin Polymers 0.000 description 15
- 239000011347 resin Substances 0.000 description 15
- 229910052759 nickel Inorganic materials 0.000 description 11
- 229910052802 copper Inorganic materials 0.000 description 10
- 229910052745 lead Inorganic materials 0.000 description 10
- 230000008569 process Effects 0.000 description 10
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 9
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 9
- 150000002739 metals Chemical class 0.000 description 9
- 229910052716 thallium Inorganic materials 0.000 description 8
- BKVIYDNLLOSFOA-UHFFFAOYSA-N thallium Chemical compound [Tl] BKVIYDNLLOSFOA-UHFFFAOYSA-N 0.000 description 8
- 238000009835 boiling Methods 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 238000005530 etching Methods 0.000 description 7
- 239000011701 zinc Substances 0.000 description 7
- 238000004458 analytical method Methods 0.000 description 6
- 239000011491 glass wool Substances 0.000 description 6
- 238000009616 inductively coupled plasma Methods 0.000 description 6
- 238000000926 separation method Methods 0.000 description 6
- -1 204Pb Chemical compound 0.000 description 5
- 230000001143 conditioned effect Effects 0.000 description 5
- 238000002955 isolation Methods 0.000 description 5
- 238000012546 transfer Methods 0.000 description 5
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 4
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 4
- 239000000908 ammonium hydroxide Substances 0.000 description 4
- 239000006227 byproduct Substances 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000002699 waste material Substances 0.000 description 4
- 229910052725 zinc Inorganic materials 0.000 description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-O ammonium group Chemical group [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 239000003456 ion exchange resin Substances 0.000 description 3
- 229920003303 ion-exchange polymer Polymers 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000002285 radioactive effect Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- JCXGWMGPZLAOME-AKLPVKDBSA-N bismuth-212 Chemical compound [212Bi] JCXGWMGPZLAOME-AKLPVKDBSA-N 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 238000002354 inductively-coupled plasma atomic emission spectroscopy Methods 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 238000011363 radioimmunotherapy Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- CHRJZRDFSQHIFI-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;styrene Chemical compound C=CC1=CC=CC=C1.C=CC1=CC=CC=C1C=C CHRJZRDFSQHIFI-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000061 acid fraction Substances 0.000 description 1
- LBDSXVIYZYSRII-IGMARMGPSA-N alpha-particle Chemical compound [4He+2] LBDSXVIYZYSRII-IGMARMGPSA-N 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- JCXGWMGPZLAOME-RNFDNDRNSA-N bismuth-213 Chemical compound [213Bi] JCXGWMGPZLAOME-RNFDNDRNSA-N 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000013522 chelant Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 150000004696 coordination complex Chemical class 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 229940127043 diagnostic radiopharmaceutical Drugs 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000004980 dosimetry Methods 0.000 description 1
- 230000005264 electron capture Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 229910052732 germanium Inorganic materials 0.000 description 1
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 238000011275 oncology therapy Methods 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000005258 radioactive decay Effects 0.000 description 1
- 239000000700 radioactive tracer Substances 0.000 description 1
- 238000011362 radionuclide therapy Methods 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 238000002603 single-photon emission computed tomography Methods 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000002626 targeted therapy Methods 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- JBQYATWDVHIOAR-UHFFFAOYSA-N tellanylidenegermanium Chemical compound [Te]=[Ge] JBQYATWDVHIOAR-UHFFFAOYSA-N 0.000 description 1
- BKVIYDNLLOSFOA-OIOBTWANSA-N thallium-201 Chemical compound [201Tl] BKVIYDNLLOSFOA-OIOBTWANSA-N 0.000 description 1
- 229940127044 therapeutic radiopharmaceutical Drugs 0.000 description 1
- ZSLUVFAKFWKJRC-UHFFFAOYSA-N thorium Chemical compound [Th] ZSLUVFAKFWKJRC-UHFFFAOYSA-N 0.000 description 1
- JFALSRSLKYAFGM-FTXFMUIASA-N uranium-233 Chemical compound [233U] JFALSRSLKYAFGM-FTXFMUIASA-N 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Classifications
-
- G—PHYSICS
- G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
- G21F—PROTECTION AGAINST X-RADIATION, GAMMA RADIATION, CORPUSCULAR RADIATION OR PARTICLE BOMBARDMENT; TREATING RADIOACTIVELY CONTAMINATED MATERIAL; DECONTAMINATION ARRANGEMENTS THEREFOR
- G21F9/00—Treating radioactively contaminated material; Decontamination arrangements therefor
- G21F9/007—Recovery of isotopes from radioactive waste, e.g. fission products
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/42—Selective adsorption, e.g. chromatography characterised by the development mode, e.g. by displacement or by elution
- B01D15/424—Elution mode
- B01D15/426—Specific type of solvent
-
- C—CHEMISTRY; METALLURGY
- C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
- C22B—PRODUCTION AND REFINING OF METALS; PRETREATMENT OF RAW MATERIALS
- C22B13/00—Obtaining lead
- C22B13/04—Obtaining lead by wet processes
-
- G—PHYSICS
- G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
- G21G—CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
- G21G1/00—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes
- G21G1/001—Recovery of specific isotopes from irradiated targets
-
- G—PHYSICS
- G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
- G21G—CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
- G21G1/00—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes
- G21G1/001—Recovery of specific isotopes from irradiated targets
- G21G2001/0094—Other isotopes not provided for in the groups listed above
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- High Energy & Nuclear Physics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Metallurgy (AREA)
- Mechanical Engineering (AREA)
- Materials Engineering (AREA)
- Manufacturing & Machinery (AREA)
- Optics & Photonics (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Manufacture And Refinement Of Metals (AREA)
- Inorganic Compounds Of Heavy Metals (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461979957P | 2014-04-15 | 2014-04-15 | |
| PCT/US2015/026015 WO2015160981A1 (en) | 2014-04-15 | 2015-04-15 | Methods and devices for isolating lead 203 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2900325T3 true ES2900325T3 (es) | 2022-03-16 |
Family
ID=54324550
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES15779451T Active ES2900325T3 (es) | 2014-04-15 | 2015-04-15 | Métodos y dispositivos para aislar el plomo 203 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US10199130B2 (enExample) |
| EP (1) | EP3131908B1 (enExample) |
| JP (2) | JP6920060B2 (enExample) |
| AU (1) | AU2015247689B2 (enExample) |
| CA (1) | CA2945759C (enExample) |
| ES (1) | ES2900325T3 (enExample) |
| WO (1) | WO2015160981A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110693076A (zh) * | 2019-08-07 | 2020-01-17 | 常德华馥生物技术有限公司 | 降低烟草浸膏中Pb和As含量的方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4011307A (en) * | 1976-06-03 | 1977-03-08 | The United States Of America As Represented By The United States Energy Research And Development Administration | Production of 203 Pb-tris-hydroxymethyl amino methane |
| CA2261772C (en) | 1996-08-26 | 2003-12-09 | Paul V. Harper | Process and apparatus for the production of bi-212 and a use thereof |
| FR2990956B1 (fr) * | 2012-05-24 | 2014-07-04 | Areva Med Sas | Procede et appareil pour la production de plomb 212 a usage medical |
-
2015
- 2015-04-15 AU AU2015247689A patent/AU2015247689B2/en active Active
- 2015-04-15 WO PCT/US2015/026015 patent/WO2015160981A1/en not_active Ceased
- 2015-04-15 ES ES15779451T patent/ES2900325T3/es active Active
- 2015-04-15 CA CA2945759A patent/CA2945759C/en active Active
- 2015-04-15 EP EP15779451.2A patent/EP3131908B1/en active Active
- 2015-04-15 JP JP2016562955A patent/JP6920060B2/ja active Active
- 2015-04-15 US US15/304,082 patent/US10199130B2/en active Active
-
2018
- 2018-12-20 US US16/228,637 patent/US10910123B2/en active Active
-
2021
- 2021-05-11 JP JP2021080487A patent/JP7225305B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US10199130B2 (en) | 2019-02-05 |
| WO2015160981A1 (en) | 2015-10-22 |
| US10910123B2 (en) | 2021-02-02 |
| CA2945759A1 (en) | 2015-10-22 |
| JP2017518867A (ja) | 2017-07-13 |
| US20190131025A1 (en) | 2019-05-02 |
| CA2945759C (en) | 2023-03-28 |
| EP3131908B1 (en) | 2021-09-22 |
| JP6920060B2 (ja) | 2021-08-18 |
| EP3131908A4 (en) | 2018-01-17 |
| AU2015247689B2 (en) | 2019-10-10 |
| AU2015247689A1 (en) | 2016-11-03 |
| US20170040074A1 (en) | 2017-02-09 |
| JP7225305B2 (ja) | 2023-02-20 |
| EP3131908A1 (en) | 2017-02-22 |
| JP2021165738A (ja) | 2021-10-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Talip et al. | A step-by-step guide for the novel radiometal production for medical applications: case studies with 68Ga, 44Sc, 177Lu and 161Tb | |
| Mikolajczak et al. | Radiometals for imaging and theranostics, current production, and future perspectives | |
| Bartoś et al. | New separation method of no-carrier-added 47Sc from titanium targets | |
| CN105899269B (zh) | 用于定量223Ra组合物中227Ac的方法 | |
| CN103003889A (zh) | 同位素制备方法 | |
| RU2768732C2 (ru) | Способ получения изотопа | |
| Andersson et al. | Robust high-yield~ 1 TBq production of cyclotron based sodium [99mTc] pertechnetate | |
| Baimukhanova et al. | An alternative radiochemical separation strategy for isolation of Ac and Ra isotopes from high energy proton irradiated thorium targets for further application in Targeted Alpha Therapy (TAT) | |
| Mohapatra et al. | Evaluation of several multiple diglycolamide-functionalized calix [4] arene ligands for the isolation of carrier free 90Y from 90Sr | |
| Saghez et al. | High separation factor, high molar activity, and inexpensive purification method for the production of pure 165Er | |
| Kazakov et al. | Separation of 89Zr from irradiated yttrium targets by extraction chromatography | |
| Schmidt et al. | Development of a SnO2-based 44Ti/44Sc generator for medical applications | |
| JP7225305B2 (ja) | 鉛２０３を単離するための方法およびデバイス | |
| Castillo et al. | Production of large quantities of 90Y by ion-exchange chromatography using an organic resin and a chelating agent | |
| Saha et al. | Purification and quality control of the radiopharmaceutical 89SrCl2 produced in FBTR | |
| Ondrák Fialová et al. | 68Ge/68Ga composite CeO2-PAN generator: preparation, testing and use | |
| Peikin et al. | Separation of terbium from proton-irradiated gadolinium oxide targets–development of an effective, scalable and automatable process | |
| ES2828599T3 (es) | Separación cromatográfica de Mo-99 de W-187 | |
| Camroodien | Development of 18F radiochemistry for positron emission particle tracking (PEPT) | |
| Silliková et al. | Sequential determination of 99Tc and 126Sn in radioactive concentrate | |
| Ruiz Quiros | A Chromatographic Method to Separate Sc (III) from Zn (II) Ions: A Step in the Purification of Sc-44 (an isotope of medical interest) | |
| Dybczyński | 50 Years of adventures with neutron activation analysis with the special emphasis on radiochemical separations | |
| Fialová et al. | 68Ge/68Ga composite CeO | |
| Brown | Investigation of the Extraction of Stable 45Sc and Carrier Free 44Sc for Theranostic Applications | |
| Braguin et al. | Separation of Sc and Ti using cation exchange resin |